In PCOS patients receiving GnRH antagonist protocols, endogenous LH was not suppressed during the early stages of Gn stimulation; thus, potential ovarian overstimulation may be inhibited by endogenous LH. Here, GNRH1 is linked to polycystic ovary syndrome.